Early safety check for experimental drugs begins
NCT ID NCT07260851
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This early-stage trial is testing the safety and how the body handles three experimental drugs—DWJ1622, DWC202313, and DWC202314—in 40 healthy adults. Participants take a single dose of each drug under fasting conditions. The study aims to measure drug levels in the blood and check for any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H Plus YANGJI Hospital
RECRUITINGSeoul, Gwanak-gu, 08779, South Korea
Contact Phone: •••-•••-••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DWJ1622, DWC202313, DWC202314 (oral drugs)
What could go wrong
This is an early Phase 1 study in healthy volunteers, so it only tests safety and drug processing—not whether the drugs work for any disease. The results may not apply to patients.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.